IBDEI1K5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25259,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25259,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,25259,1,3,0)
 ;;=3^FLU VACCINE SINGLE DOSE SYR (AFLURIA IIV3)
 ;;^UTILITY(U,$J,358.3,25260,0)
 ;;=90691^^91^1146^40^^^^1
 ;;^UTILITY(U,$J,358.3,25260,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25260,1,2,0)
 ;;=2^90691
 ;;^UTILITY(U,$J,358.3,25260,1,3,0)
 ;;=3^TYPHOID VACCINE IM
 ;;^UTILITY(U,$J,358.3,25261,0)
 ;;=90670^^91^1146^32^^^^1
 ;;^UTILITY(U,$J,358.3,25261,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25261,1,2,0)
 ;;=2^90670
 ;;^UTILITY(U,$J,358.3,25261,1,3,0)
 ;;=3^PREVNAR 13 (PNEUMOCOCCAL VACCINE)
 ;;^UTILITY(U,$J,358.3,25262,0)
 ;;=90662^^91^1146^8^^^^1
 ;;^UTILITY(U,$J,358.3,25262,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25262,1,2,0)
 ;;=2^90662
 ;;^UTILITY(U,$J,358.3,25262,1,3,0)
 ;;=3^FLU VACCINE HIGH DOSE SYRINGE (FLUZONE)
 ;;^UTILITY(U,$J,358.3,25263,0)
 ;;=90697^^91^1146^5^^^^1
 ;;^UTILITY(U,$J,358.3,25263,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25263,1,2,0)
 ;;=2^90697
 ;;^UTILITY(U,$J,358.3,25263,1,3,0)
 ;;=3^DTAP-IPV-HIB-HEPB VACCINE IM
 ;;^UTILITY(U,$J,358.3,25264,0)
 ;;=90625^^91^1146^2^^^^1
 ;;^UTILITY(U,$J,358.3,25264,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25264,1,2,0)
 ;;=2^90625
 ;;^UTILITY(U,$J,358.3,25264,1,3,0)
 ;;=3^CHOLERA VACCINE,ORAL
 ;;^UTILITY(U,$J,358.3,25265,0)
 ;;=90620^^91^1146^27^^^^1
 ;;^UTILITY(U,$J,358.3,25265,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25265,1,2,0)
 ;;=2^90620
 ;;^UTILITY(U,$J,358.3,25265,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE,PROTEIN/OUT MEM IM
 ;;^UTILITY(U,$J,358.3,25266,0)
 ;;=90621^^91^1146^26^^^^1
 ;;^UTILITY(U,$J,358.3,25266,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25266,1,2,0)
 ;;=2^90621
 ;;^UTILITY(U,$J,358.3,25266,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE,LIPOPROTEIN IM
 ;;^UTILITY(U,$J,358.3,25267,0)
 ;;=90686^^91^1146^7^^^^1
 ;;^UTILITY(U,$J,358.3,25267,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25267,1,2,0)
 ;;=2^90686
 ;;^UTILITY(U,$J,358.3,25267,1,3,0)
 ;;=3^FLU VACC SGLE DOSE SYR (AFLURIA IIV4)
 ;;^UTILITY(U,$J,358.3,25268,0)
 ;;=90674^^91^1146^11^^^^1
 ;;^UTILITY(U,$J,358.3,25268,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25268,1,2,0)
 ;;=2^90674
 ;;^UTILITY(U,$J,358.3,25268,1,3,0)
 ;;=3^FLU VACCINE LOW DOSE SYR (FLUCELVAX ccIIV4)
 ;;^UTILITY(U,$J,358.3,25269,0)
 ;;=90672^^91^1146^10^^^^1
 ;;^UTILITY(U,$J,358.3,25269,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25269,1,2,0)
 ;;=2^90672
 ;;^UTILITY(U,$J,358.3,25269,1,3,0)
 ;;=3^FLU VACCINE INTRANASAL,QUADRIVALENT,LIVE
 ;;^UTILITY(U,$J,358.3,25270,0)
 ;;=90688^^91^1146^13^^^^1
 ;;^UTILITY(U,$J,358.3,25270,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25270,1,2,0)
 ;;=2^90688
 ;;^UTILITY(U,$J,358.3,25270,1,3,0)
 ;;=3^FLU VACCINE MULTI DOSE VL (AFLURIA IIV4)
 ;;^UTILITY(U,$J,358.3,25271,0)
 ;;=90682^^91^1146^15^^^^1
 ;;^UTILITY(U,$J,358.3,25271,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25271,1,2,0)
 ;;=2^90682
 ;;^UTILITY(U,$J,358.3,25271,1,3,0)
 ;;=3^FLUBLOK (RIV4)
 ;;^UTILITY(U,$J,358.3,25272,0)
 ;;=90759^^91^1146^19^^^^1
 ;;^UTILITY(U,$J,358.3,25272,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25272,1,2,0)
 ;;=2^90759
 ;;^UTILITY(U,$J,358.3,25272,1,3,0)
 ;;=3^HEP B VACCINE 3-ANTIGEN 10 MCG 3 DOSE SCH IM
 ;;^UTILITY(U,$J,358.3,25273,0)
 ;;=90626^^91^1146^38^^^^1
 ;;^UTILITY(U,$J,358.3,25273,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25273,1,2,0)
 ;;=2^90626
